{"id":51,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2014-10-23","marketCap":294.869,"name":"Soleno Therapeutics Inc","phone":"16502138444.0","outstanding":9.99,"symbol":"SLNO","website":"https://soleno.life/","industry":"Biotechnology"},"price":25.1075,"year":2023,"month":9,"day":29,"weekday":"Friday","title":"Corporate Governance Practices of Soleno Therapeutics Inc","date":"2023-09-29","url":"/posts/2023/09/29/SLNO","content":[{"section":"Board Composition","text":"Soleno Therapeutics Inc has a board of directors consisting of highly experienced individuals from diverse backgrounds, including medical professionals, pharmaceutical executives, and experts in finance and governance. The board is composed of both independent directors and executives of the company."},{"section":"Independence","text":"Soleno Therapeutics Inc ensures a majority of independent directors on its board. This practice enhances the objectivity and accountability of decision-making within the company."},{"section":"Committees","text":"The board of Soleno Therapeutics Inc has established various committees to oversee specific areas of corporate governance. These committees include an audit committee, compensation committee, and nominating and corporate governance committee. Each committee is comprised of independent directors and is responsible for providing oversight and making recommendations in their respective areas."},{"section":"Executive Compensation","text":"Soleno Therapeutics Inc follows a transparent and performance-based approach to executive compensation. The compensation committee, which comprises independent directors, determines the compensation packages for executives. These packages are typically aligned with the company's financial performance, shareholder returns, and individual performance objectives."},{"section":"Equity Incentives","text":"Soleno Therapeutics Inc utilizes equity incentives, such as stock options and restricted stock units, to align the interests of executives with those of the shareholders. These incentives ensure that executives have a vested interest in the long-term success and value creation of the company."},{"section":"Share Ownership Guidelines","text":"Soleno Therapeutics Inc has implemented share ownership guidelines for executives, requiring them to hold a certain number of shares of the company's stock. This practice promotes a stronger alignment between executive decision-making and shareholder interests."},{"section":"Regular Board Evaluations","text":"Soleno Therapeutics Inc conducts regular evaluations of its board of directors to assess their performance, independence, and effectiveness. These evaluations help identify areas for improvement and ensure the board remains dynamic and responsive to the company's strategic objectives."},{"section":"Risk Oversight","text":"The board of Soleno Therapeutics Inc actively oversees the company's risk management processes. It assesses and monitors risks related to operations, finance, compliance, and strategic decisions. This approach helps safeguard the interests of shareholders and ensures the company's long-term sustainability."}],"tags":["stock","Long","Biotechnology"],"news":[{"category":"company","date":1695958260,"headline":"Insider Trading: Soleno (NASDAQ:SLNO) Top Insider Buys This Rising Stock","id":122865167,"image":"","symbol":"SLNO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3138314957"},{"category":"company","date":1695953400,"headline":"Soleno Therapeutics' 10% owner buys $15M worth of stock","id":122865168,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3138253347"},{"category":"company","date":1695909480,"headline":"Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT \u0026 PLRX Gain on Study Data","id":122837618,"image":"https://media.zenfs.com/en/zacks.com/90506238aa638530d9b23cf02b58df25","symbol":"SLNO","publisher":"Yahoo","summary":"Acquisition news from Intercept (ICPT) and study updates from Immunovant (IMVT) are in focus in the biotech sector.","url":"https://finance.yahoo.com/news/biotech-stock-roundup-icpt-buyout-135800436.html"},{"category":"company","date":1695904200,"headline":"Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants","id":122837620,"image":"https://media.zenfs.com/en/globenewswire.com/f08853057f613e1bc8d5445e6fb26887","symbol":"SLNO","publisher":"Yahoo","summary":"REDWOOD CITY, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $20.00 per share. The gross proceeds of the public offering are expected to be approximately $60.0 million, before deducting the u","url":"https://finance.yahoo.com/news/soleno-therapeutics-announces-pricing-approximately-123000458.html"},{"category":"company","date":1695902760,"headline":"Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":122836193,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137163760"},{"category":"company","date":1695895320,"headline":"Soleno Therapeutics prices its underwritten public offering at $20 per share","id":122865170,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137001205"},{"category":"company","date":1695894180,"headline":"Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday","id":122836162,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3136976273"},{"category":"company","date":1695891720,"headline":"Acadia Pharmaceuticals, XWELL among healthcare movers","id":122835535,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3136925852"},{"category":"company","date":1695888720,"headline":"12 Health Care Stocks Moving In Thursday's Pre-Market Session","id":122835239,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3136865667"},{"category":"company","date":1695887100,"headline":"GME, SSL and GRTS are among pre market gainers","id":122835853,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3136835219"},{"category":"company","date":1695886500,"headline":"Soleno Therapeutics 3M share Spot Secondary priced at $20.00","id":122865176,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3136825073"},{"category":"company","date":1695848100,"headline":"Why Shares of Soleno Therapeutics Dropped on Wednesday","id":122825706,"image":"","symbol":"SLNO","publisher":"Yahoo","summary":"Shares of Soleno Therapeutics (NASDAQ: SLNO) were down more than 23% as of 3 p.m. on Wednesday, a day after the pharmaceutical stock rose as much as 420% on news regarding its prospective treatment for Prader-Willi Syndrome (PWS), a rare genetic disorder.  Thanks to the rise, even with Soleno's shares falling on Wednesday, sellers were bound to make money, assuming they bought the stock as late as Monday when it was as high as only $4.86 a share.  On Tuesday, the clinical-stage biotech said that it planned to submit a New Drug Application (NDA) to the Food and Drug Administration (FDA) regarding diazoxide choline controlled-release (DCCR) to treat PWS.","url":"https://finance.yahoo.com/m/c8c38d16-ed56-35bc-89d2-38be703ae694/why-shares-of-soleno.html"},{"category":"company","date":1695844860,"headline":"Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants","id":122825707,"image":"https://media.zenfs.com/en/globenewswire.com/f08853057f613e1bc8d5445e6fb26887","symbol":"SLNO","publisher":"Yahoo","summary":"REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell shares of its common stock and/or pre-funded warrants in an underwritten public offering. In addition, Soleno intends to grant the underwriters a 30-day option to purchase an additional number of shares of common s","url":"https://finance.yahoo.com/news/soleno-therapeutics-announces-proposed-public-200100341.html"},{"category":"company","date":1695835680,"headline":"Soleno Therapeutics Stock Dives After Its Meteoric Rise on Positive Study Results","id":122825708,"image":"","symbol":"SLNO","publisher":"Yahoo","summary":"Soleno Therapeutics  stock fell sharply Wednesday, reversing a small portion of its meteoric gains from the previous session.  The biotechnology company’s shares had skyrocketed 505% on Tuesday to $26.80, marking the stock’s largest percentage increase on record and its highest close since March 2021, according to Dow Jones Market Data.  Prader-Willi Syndrome affects metabolism, and its hallmark symptom is hyperphagia—a chronic feeling of intense, persistent hunger and an intense drive to consume food.","url":"https://finance.yahoo.com/m/0a1ea4ab-294e-3e4a-8bc7-3138e40badf3/soleno-therapeutics-stock.html"},{"category":"company","date":1695819000,"headline":"ACST, TRT and CNTX among mid-day movers","id":122808658,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135468512"},{"category":"company","date":1695815520,"headline":"Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session","id":122806249,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135388048"},{"category":"company","date":1695813660,"headline":"Soleno (SLNO) Soars as Prader-Willi Syndrome Study Meets Goal","id":122803054,"image":"https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea","symbol":"SLNO","publisher":"Yahoo","summary":"Soleno's (SLNO) shares rally as the late-stage study evaluating diazoxide choline for patients with Prader-Willi syndrome meets its primary and secondary endpoints.","url":"https://finance.yahoo.com/news/soleno-slno-soars-prader-willi-112100382.html"},{"category":"company","date":1695811996,"headline":"Individual investors in Soleno Therapeutics, Inc. (NASDAQ:SLNO) are its biggest bettors, and their bets paid off as stock gained 494% last week","id":122803055,"image":"https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","symbol":"SLNO","publisher":"Yahoo","summary":"Key Insights Soleno Therapeutics' significant individual investors ownership suggests that the key decisions are...","url":"https://finance.yahoo.com/news/individual-investors-soleno-therapeutics-inc-105316851.html"},{"category":"company","date":1695799140,"headline":"SLNO, AXLA and VACC among pre-market losers","id":122807207,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135039004"},{"category":"company","date":1695794040,"headline":"Fly Intel: After-Hours Movers","id":122821301,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135927474"},{"category":"company","date":1695786960,"headline":"Soleno Therapeutics up 7% after stock offering, investor purchase agreement","id":122816790,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135740287"},{"category":"company","date":1695785640,"headline":"Soleno Therapeutics $60M Spot Secondary; price range $20.00","id":122816791,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135707252"},{"category":"company","date":1695784260,"headline":"Soleno Therapeutics proposes public offering of common stock","id":122816793,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135670631"},{"category":"company","date":1695783840,"headline":"Soleno Therapeutics files to sell common stock, no amount given","id":122816794,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135662200"},{"category":"company","date":1695782100,"headline":"Don’t Miss the Boom: 3 ETFs Set to Explode Higher","id":122815021,"image":"","symbol":"SLNO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135618787"},{"category":"company","date":1695769774,"headline":"Wall St pounded as investors grapple with higher rates","id":122796987,"image":"https://static.reuters.com/resources/r/?m=02\u0026d=20230926\u0026t=2\u0026i=1645813289\u0026r=LYNXMPEJ8P09Y","symbol":"SLNO","publisher":"Reuters","summary":"Wall Street's main indexes ended down over 1% on Tuesday as 10-year Treasury yields held their multi-year highs, with investors still wrestling with prospects for a long period of high interest rates and the economic fallout.","url":"https://www.reuters.com/article/usa-stocks/wall-st-pounded-as-investors-grapple-with-higher-rates-idUSKBN30W0MH"},{"category":"company","date":1695769631,"headline":"Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation","id":122795402,"image":"","symbol":"SLNO","publisher":"Fintel","summary":"","url":"https://fintel.io/news/cantor-fitzgerald-maintains-soleno-therapeutics-slno-overweight-recommendation-994"},{"category":"company","date":1695759096,"headline":"Soleno Catapults 505% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease","id":122798705,"image":"","symbol":"SLNO","publisher":"Yahoo","summary":"Soleno said Tuesday its experimental pill helped control hunger signals in a genetic disorder. In response, SLNO stock skyrocketed.","url":"https://finance.yahoo.com/m/1b195175-a14f-3ab4-9d5b-2183e02db62c/soleno-catapults-505%25-after.html"},{"category":"company","date":1695758446,"headline":"US STOCKS-Wall St pounded as investors grapple with higher rates","id":122796988,"image":"","symbol":"SLNO","publisher":"Reuters","summary":"Wall Street's main indexes ended sharply lower on Tuesday as 10-year Treasury yields held their multi-year highs, with investors still wrestling with prospects for a long period of high interest rates and the economic fallout.","url":"https://www.reuters.com/article/usa-stocks/us-stocks-wall-st-pounded-as-investors-grapple-with-higher-rates-idUSL1N3B22G3"},{"category":"company","date":1695752227,"headline":"US STOCKS-Wall St slides over 1% as Treasury yields hover at 16-year peaks","id":122796990,"image":"","symbol":"SLNO","publisher":"Reuters","summary":"Wall Street's main indexes sank over 1% on Tuesday as 10-year Treasury yields held their multi-year highs, with investors still wrestling with prospects for a long period of high interest rates and the economic fallout.","url":"https://www.reuters.com/article/usa-stocks/us-stocks-wall-st-slides-over-1-as-treasury-yields-hover-at-16-year-peaks-idUSL1N3B2290"},{"category":"company","date":1695747104,"headline":"Why Shares of Soleno Therapeutics Are Booming on Tuesday","id":122787509,"image":"https://s.yimg.com/ny/api/res/1.2/HALjF1o0ma4_ECG87cC98A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/b7bddc6100204971adfd9c95f969ef91","symbol":"SLNO","publisher":"Yahoo","summary":"Shares of Soleno Therapeutics (NASDAQ: SLNO) were up more than 372% as of 12:30 p.m. on Tuesday.  On Tuesday, before the markets opened, it announced that its lead pipeline candidate, diazoxide choline controlled-release (DCCR), an extended-release pill to treat Prader-Willi syndrome (PWS), showed a dramatic improvement in hyperphagia-related behaviors compared to a placebo.  The company said it plans to submit a New Drug Application (NDA) to the Food and Drug Administration (FDA) for DCCR to treat PWS.","url":"https://finance.yahoo.com/m/2e5238e7-efdb-3968-88a7-9ea00a2930bd/why-shares-of-soleno.html"},{"category":"company","date":1695745975,"headline":"Wall St slides as rate concerns keep Treasury yields near 16-year peak","id":122783875,"image":"https://static.reuters.com/resources/r/?m=02\u0026d=20230926\u0026t=2\u0026i=1645813289\u0026r=LYNXMPEJ8P09Y","symbol":"SLNO","publisher":"Reuters","summary":"Wall Street's main indexes dived on Tuesday as 10-year Treasury yields held their multi-year highs, with investors continuing to grapple with the prospects of a prolonged restrictive monetary policy and its subsequent economic impact.","url":"https://www.reuters.com/article/usa-stocks/wall-st-slides-as-rate-concerns-keep-treasury-yields-near-16-year-peak-idUSKBN30W0MH"},{"category":"company","date":1695745971,"headline":"US STOCKS-Wall St slides as rate concerns keep Treasury yields near 16-year peak","id":122796991,"image":"","symbol":"SLNO","publisher":"Reuters","summary":"Wall Street's main indexes dived on Tuesday as 10-year Treasury yields held their multi-year highs, with investors continuing to grapple with the prospects of a prolonged restrictive monetary policy and its subsequent economic impact.","url":"https://www.reuters.com/article/usa-stocks/us-stocks-wall-st-slides-as-rate-concerns-keep-treasury-yields-near-16-year-peak-idUSL4N3B23EG"},{"category":"company","date":1695745056,"headline":"Soleno Catapults Almost 400% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease","id":122787510,"image":"","symbol":"SLNO","publisher":"Yahoo","summary":"Soleno said Tuesday its experimental pill helped control hunger signals in a genetic disorder. In response, SLNO stock skyrocketed.","url":"https://finance.yahoo.com/m/1b195175-a14f-3ab4-9d5b-2183e02db62c/soleno-catapults-almost-400%25.html"},{"category":"company","date":1695732480,"headline":"APLT, VCNX and FRES among mid-day movers","id":122783838,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133763132"},{"category":"company","date":1695731640,"headline":"12 Health Care Stocks Moving In Tuesday's Intraday Session","id":122782983,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133745245"},{"category":"company","date":1695729600,"headline":"Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session","id":122781983,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133700331"},{"category":"company","date":1695727800,"headline":"Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from  Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome","id":122787511,"image":"https://media.zenfs.com/en/globenewswire.com/f08853057f613e1bc8d5445e6fb26887","symbol":"SLNO","publisher":"Yahoo","summary":"Study Met Primary Endpoint; Highly Statistically Significant Difference in Change from Baseline in HQ-CT Total Score for DCCR Compared to Placebo (p=0.0022) Soleno Intends to Submit a New Drug Application for DCCR in PWS Mid-Year 2024 Company to Host Conference Call and Webcast Today at 9:00 AM ET REDWOOD CITY, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- September 26, 2023 – Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics","url":"https://finance.yahoo.com/news/soleno-therapeutics-announces-positive-statistically-113000169.html"},{"category":"company","date":1695726540,"headline":"Crude Oil Moves Higher; Cintas Earnings Top Estimates","id":122780094,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133633807"},{"category":"company","date":1695726180,"headline":"Soleno Therapeutics Shares Take Flight After Strong Study Data","id":122849453,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"SLNO","publisher":"MarketWatch","summary":"By Colin Kellaher Soleno Therapeutics shares more than quadrupled on Tuesday after the biopharmaceutical company reported strong long-term data for its...","url":"https://www.marketwatch.com/story/soleno-therapeutics-shares-take-flight-after-strong-study-data-cd73d5f5"},{"category":"company","date":1695723300,"headline":"Soleno Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald","id":122780095,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133565388"},{"category":"company","date":1695721980,"headline":"Why Is Canopy Growth (CGC) Stock Up 9% Today?","id":122780097,"image":"","symbol":"SLNO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133536676"},{"category":"company","date":1695721620,"headline":"Soleno surges on data for lead asset in Prader-Willi syndrome","id":122780098,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133530304"},{"category":"company","date":1695720960,"headline":"RIVN Stock Alert: Baird Expects Rivian to Outperform in Q3","id":122780099,"image":"","symbol":"SLNO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133515855"},{"category":"company","date":1695720360,"headline":"Why Is Soleno Therapeutics (SLNO) Stock Up 420% Today?","id":122780100,"image":"","symbol":"SLNO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133502801"},{"category":"company","date":1695718260,"headline":"Dow Tumbles 150 Points; US House Prices Rise in July","id":122779959,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133461830"},{"category":"company","date":1695715860,"headline":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session","id":122780102,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133414042"},{"category":"company","date":1695715200,"headline":"Fly Intel: Pre-market Movers","id":122780057,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133399974"},{"category":"company","date":1695714660,"headline":"Soleno Therapeutics Shares Soar Premarket on Prader-Willi Study Success","id":122849454,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"SLNO","publisher":"MarketWatch","summary":"By Colin Kellaher Shares of Soleno Therapeutics surged more than 50% in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported...","url":"https://www.marketwatch.com/story/soleno-therapeutics-shares-soar-premarket-on-prader-willi-study-success-cc682f6f"},{"category":"company","date":1695713220,"headline":"ADPT and CURV among pre-market gainers","id":122780106,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133364972"},{"category":"company","date":1695713220,"headline":"Soleno Therapeutics up 190% in pre-market after DCCR study data","id":122780105,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133365349"},{"category":"company","date":1695710820,"headline":"Soleno announces statistically significant top-line results from Study C602","id":122780107,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133326751"},{"category":"company","date":1695694800,"headline":"Soleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatment","id":122816799,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133886768"},{"category":"company","date":1695691920,"headline":"Soleno Therapeutics price target raised to $39 from $14 at Oppenheimer","id":122816801,"image":"","symbol":"SLNO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133822322"},{"category":"company","date":1695691920,"headline":"Nasdaq Down 1.5%; Immunovant Shares Spike Higher","id":122786341,"image":"","symbol":"SLNO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133822445"},{"category":"company","date":1695643200,"headline":"Soleno Therapeutics to Present at the Cantor Global Healthcare Conference","id":122758892,"image":"https://media.zenfs.com/en/globenewswire.com/f08853057f613e1bc8d5445e6fb26887","symbol":"SLNO","publisher":"Yahoo","summary":"REDWOOD CITY, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the Cantor Global Healthcare Conference on Tuesday, September 26, 2023 at 8:10 AM Eastern Time. A live audio webcast and replay of the presentation will be available in the Investors section on th","url":"https://finance.yahoo.com/news/soleno-therapeutics-present-cantor-global-120000126.html"},{"category":"company","date":1695632580,"headline":"High Tide, Alector among healthcare movers","id":122763263,"image":"","symbol":"SLNO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3131914117"}]}